Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
174 AATD-related liver diseases have a highly variable clinical phenotype, suggesting that disease progression is strongly influenced by environmental and genetic modifiers
C.CabralM
Study design is virtually complete and is expected to be a 5-week parallel group design, investigating 3 separate arms to assess safety & tolerability and pharmacokinetic ("PK") properties that will compare salcaprozate sodium ("SNAC")-inclusive DHT-sema tablet and capsule formulations to commercially available Wegovy tablets, under fasted pre-dose conditions
Meet Your Provider Join your video visit from any private location
US$ 27.52
US$ 27.06
US$ 25.99
US$ 22.17
US$ 28.64
US$ 27.73
US$ 29.33
